Main menu

NEW YORK (GenomeWeb News) – Gen-Probe said after the close of the market on Wednesday that an arbitration panel has ruled in favor of it and Roche against Qiagen regarding Gen-Probe's supply and purchase agreement with Roche for human papillomavirus products.

San Diego-based Gen-Probe said that a three-member arbitration panel from the International Centre for Dispute Resolution issued an interim award that dismisses all of Qiagen's claims. The firm said that it expects the award to remain unchanged, though it is subject to further proceedings related to its implementation.

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.

This webinar describes a study that used two independent next-generation sequencing (NGS) platforms to gain insight into the impact of different types of aneuploidies during preimplantation genetic testing.